LIVZON PHARMAC. GRP H YC1 (LP6) — Cash Flow Reinvestment Rate
LIVZON PHARMAC. GRP H YC1 (LP6) has a Cash Flow Reinvestment Rate of 0.60x as of December 2025, reinvesting €1.90 Billion (capex €574.14 Million plus investments €-1.33 Billion) from operating cash flow of €3.15 Billion. Explore capital reinvestment ratio of LIVZON PHARMAC. GRP H YC1 to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
LIVZON PHARMAC. GRP H YC1 Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for LIVZON PHARMAC. GRP H YC1 across 5 annual periods. Also explore total assets of LIVZON PHARMAC. GRP H YC1 for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for LIVZON PHARMAC. GRP H YC1 (2021–2025)
Year-by-year capital reinvestment analysis for LIVZON PHARMAC. GRP H YC1. For live market cap and broader valuation context, see how much is LIVZON PHARMAC. GRP H YC1 worth.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.60x | €1.90 Billion | €3.15 Billion | €574.14 Million | ▲ +174.0% |
| 2024 | 0.22x | €656.96 Million | €2.98 Billion | €570.16 Million | ▼ -25.7% |
| 2023 | 0.30x | €964.13 Million | €3.25 Billion | €820.45 Million | ▼ -31.9% |
| 2022 | 0.44x | €1.21 Billion | €2.77 Billion | €940.15 Million | ▼ -56.0% |
| 2021 | 0.99x | €1.89 Billion | €1.90 Billion | €1.31 Billion | — |